Costs and benefits of diagnostic testing: four ways to improve patient care by purposive use of in vitro diagnostics
Scientific advances and innovative targeted drugs, especially biologics, have revolutionised the treatment of many diseases. In oncology in particular, previously acute or lethal conditions have come to be considered chronic as new treatments have led to longer life expectancies and a lower rate o...
Main Authors: | Carmen Binder, Maximilian Schmid, Thomas Dieterle, Hans Hendrik Schäfer |
---|---|
Format: | Article |
Language: | English |
Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2017-11-01
|
Series: | Swiss Medical Weekly |
Subjects: | |
Online Access: | https://www.smw.ch/index.php/smw/article/view/2419 |
Similar Items
-
A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics
by: Dee eLuo, et al.
Published: (2016-01-01) -
Applications and regulatory of nanotechnology‐based innovative in vitro diagnostics
by: Kuan Chen, et al.
Published: (2021-04-01) -
The Potential of a Stratified Approach to Drug Repurposing in Alzheimer’s Disease
by: Chloe Anderson, et al.
Published: (2023-12-01) -
How personalised medicine will transform healthcare by 2030: the ICPerMed vision
by: Astrid M. Vicente, et al.
Published: (2020-04-01) -
Evaluation of human T-cell leukemia virus in vitro diagnostics using plasma specimens collected in Japan
by: Shigeru Kusagawa, et al.
Published: (2023-06-01)